There have been reports of patients who used the drug being diagnosed with severe gastroparesis, or stomach paralysis
Weekly subcutaneous injections are titrated based on your tolerance and weight loss progress
A phase 2B, randomised, double-blind, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of VK2809 administered for 52 Weeks followed by a 4-week off-drug phase in subjects with biopsy proven non-alcoholic steatohepatitis with fibrosis
Stick with the titration plan
Injections or pre-filled pens should be administered weekly subcutaneously (under the skin, in areas such as the thighs or upper arms)
By using the lowest effective dose, this method reduces side effects, supports muscle preservation, and delivers strong results with a much more comfortable experience